David D. Davey

792 total citations
17 papers, 381 citations indexed

About

David D. Davey is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, David D. Davey has authored 17 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in David D. Davey's work include Synthesis and Reactions of Organic Compounds (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). David D. Davey is often cited by papers focused on Synthesis and Reactions of Organic Compounds (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). David D. Davey collaborates with scholars based in United States. David D. Davey's co-authors include Gary B. Phillips, Marc Whitlow, Marc Adler, David R. Light, Galina Rumennik, Sung‐Hou Kim, Jarmila Jancarik, W. R. Ingebretsen, Paul Erhardt and Amy Liang and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

David D. Davey

17 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David D. Davey United States	11	170	154	76	53	49	17	381
Michael R. Becker United States	7	113 0.7×	128 0.8×	100 1.3×	72 1.4×	42 0.9×	9	303
Yong Mi Choi-Sledeski United States	9	115 0.7×	153 1.0×	99 1.3×	76 1.4×	42 0.9×	12	327
Shuaige Wang United States	8	171 1.0×	80 0.5×	103 1.4×	27 0.5×	60 1.2×	9	330
Kurt Hilpert Switzerland	12	162 1.0×	235 1.5×	109 1.4×	53 1.0×	75 1.5×	19	478
James R. Corte United States	13	227 1.3×	102 0.7×	64 0.8×	30 0.6×	22 0.4×	20	383
Christopher A. Teleha United States	13	393 2.3×	234 1.5×	70 0.9×	28 0.5×	66 1.3×	32	668
Bobby J. Lucas United States	14	274 1.6×	249 1.6×	164 2.2×	42 0.8×	56 1.1×	21	529
Werner W. K. R. Mederski Germany	12	345 2.0×	210 1.4×	28 0.4×	75 1.4×	54 1.1×	26	539
John M. Fevig United States	13	381 2.2×	173 1.1×	165 2.2×	31 0.6×	100 2.0×	21	641
Tammy C. Wang United States	10	113 0.7×	98 0.6×	52 0.7×	14 0.3×	46 0.9×	16	278

Countries citing papers authored by David D. Davey

Since Specialization

Citations

This map shows the geographic impact of David D. Davey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Davey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Davey more than expected).

Fields of papers citing papers by David D. Davey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Davey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Davey. The network helps show where David D. Davey may publish in the future.

Co-authorship network of co-authors of David D. Davey

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Davey. A scholar is included among the top collaborators of David D. Davey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Davey. David D. Davey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ye, Bin, John G. Bauman, David D. Davey, et al.. (2008). Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase. Bioorganic & Medicinal Chemistry Letters. 18(14). 3891–3894. 11 indexed citations

Whitlow, Marc, Marc Adler, David D. Davey, et al.. (2007). The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase. Bioorganic & Medicinal Chemistry Letters. 17(9). 2505–2508. 6 indexed citations

Adler, Marc, David D. Davey, Elena Ho, et al.. (2007). 1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation. Bioorganic & Medicinal Chemistry Letters. 17(9). 2499–2504. 8 indexed citations

Davey, David D., Keith Eagen, Brian D. Griedel, et al.. (2003). Structure–Activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(3). 507–511. 30 indexed citations

Phillips, Gary B., William J. Guilford, Brad O. Buckman, et al.. (2002). Design, Synthesis, and Activity of a Novel Series of Factor Xa Inhibitors: Optimization of Arylamidine Groups. Journal of Medicinal Chemistry. 45(12). 2484–2493. 18 indexed citations

Adler, Marc, David D. Davey, Gary B. Phillips, et al.. (2000). Preparation, Characterization, and the Crystal Structure of the Inhibitor ZK-807834 (CI-1031) Complexed with Factor Xa^,. Biochemistry. 39(41). 12534–12542. 98 indexed citations

Whitlow, Marc, Brad O. Buckman, David D. Davey, et al.. (1999). Crystallographic analysis of potent and selective factor Xa inhibitors complexed to bovine trypsin. Acta Crystallographica Section D Biological Crystallography. 55(8). 1395–1404. 30 indexed citations

Phillips, Gary B., David D. Davey, Keith Eagen, et al.. (1999). Design, Synthesis, and Activity of 2,6-Diphenoxypyridine-Derived Factor Xa Inhibitors. Journal of Medicinal Chemistry. 42(10). 1749–1756. 29 indexed citations

Davey, David D., et al.. (1991). Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogs. Journal of Medicinal Chemistry. 34(9). 2671–2677. 37 indexed citations

10.

Erhardt, Paul, et al.. (1989). Cardiotonic agents. 5. Fragments from the heterocycle-phenyl-imidazole pharmacophore. Journal of Medicinal Chemistry. 32(6). 1173–1176. 21 indexed citations

11.

Davey, David D. & William C. Lumma. (1989). Convenient synthesis of 4-methylhistamine and racemic .alpha.,4-dimethylhistamine and .alpha.,4-dimethylhistidine. The Journal of Organic Chemistry. 54(13). 3211–3213. 8 indexed citations

12.

Davey, David D.. (1987). Synthesis of 6-phenylimidazo[1,2-a]pyrazin-8-one and 1-methyl-6-phenylimidazo[1,5-a]pyrazin-8-one via quaternary intermediates. The Journal of Organic Chemistry. 52(19). 4379–4381. 19 indexed citations

13.

Lumma, William C., David D. Davey, Thomas M. Argentieri, et al.. (1987). Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents. Journal of Medicinal Chemistry. 30(5). 755–758. 33 indexed citations

14.

Davey, David D.. (1987). Synthesis of novel 8-arylimidazo[1,2-a]pryidines and 8-arylimidazo[1,5-a]pyridines. The Journal of Organic Chemistry. 52(9). 1863–1867. 21 indexed citations

15.

Lumma, William C., et al.. (1986). Synthesis and Class III antiarrhythmic activity of (phenyl-2-butenyl)ammonium salts. Effect of conformation on activity. Journal of Medicinal Chemistry. 29(8). 1398–1405. 8 indexed citations

16.

Davey, David D., et al.. (1984). Inhibition of cholesterol oxidase in a patient with Cushing's syndrome.. Clinical Chemistry. 30(4). 572–574. 3 indexed citations

17.

Davey, David D., et al.. (1983). Evaluation of a solid-phase enzyme immunoassay for human choriogonadotropin beta subunit.. Clinical Chemistry. 29(11). 1964–1966. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact